Kuntai Capsule Improves Ovarian Function in Rats with Premature Ovarian Failure After Transplantation of Cryopreserved Ovarian Tissue by Regulating Sex Hormones and Apoptosis.
IF 1.9 4区 医学Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE
Kang Yu, Chunli Wu, Yan Lang, Xin Zhou, Guohui Ren, Yanmin Li
{"title":"Kuntai Capsule Improves Ovarian Function in Rats with Premature Ovarian Failure After Transplantation of Cryopreserved Ovarian Tissue by Regulating Sex Hormones and Apoptosis.","authors":"Kang Yu, Chunli Wu, Yan Lang, Xin Zhou, Guohui Ren, Yanmin Li","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Our study aimed to investigate the therapeutic effects of the Kuntai capsule in improving ovarian function in rats with transplantation of cryopreserved ovary.</p><p><strong>Methods: </strong>Two mice ovary cell lines were cultured with Kuntai capsule decoction, and cell apoptosis was detected by MTT assay. A total of 90 SPF Sprague Dawley rats were included in this study. Thirty rats were used as the control group (group A), and not treated with any surgical operation. The remaining 60 rats were subjected to surgery to collect ovarian tissues and to construct a premature ovarian failure model. Ovarian tissues were cryopreserved, thawed, and transplanted back to ovaries. Sixty rats with ovary transplantation were randomly divided into group B and group C. Rats in group B were treated with Kuntai capsule at a dose of 0.1 capsule per day while rats in group C were fed with normal food. Serum levels of estradiol (E2) and follicular stimulating hormone (FSH) were detected. Expressions of several cytokines, including hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF-1), and apoptotic factors caspase-3 and p53, were also detected.</p><p><strong>Results: </strong>Kuntai capsule decoction inhibited apoptosis of in vitro cultured mice ovary cells. Furthermore, the Kuntai capsule promoted the recovery of E2 and FSH to normal levels and regulated the abnormal expression of HGF, VEGF, and IGF-1 and apoptotic factors caspase-3 and p53 in rats with premature ovarian failure after homotopic transplantation of ovarian tissue.</p><p><strong>Conclusion: </strong>The Kuntai capsule can improve ovarian functions by regulating sexual hormones and cell apoptosis in rats with premature ovarian failure after homotopic transplantation of cryopreserved ovary tissue.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alternative therapies in health and medicine","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Our study aimed to investigate the therapeutic effects of the Kuntai capsule in improving ovarian function in rats with transplantation of cryopreserved ovary.
Methods: Two mice ovary cell lines were cultured with Kuntai capsule decoction, and cell apoptosis was detected by MTT assay. A total of 90 SPF Sprague Dawley rats were included in this study. Thirty rats were used as the control group (group A), and not treated with any surgical operation. The remaining 60 rats were subjected to surgery to collect ovarian tissues and to construct a premature ovarian failure model. Ovarian tissues were cryopreserved, thawed, and transplanted back to ovaries. Sixty rats with ovary transplantation were randomly divided into group B and group C. Rats in group B were treated with Kuntai capsule at a dose of 0.1 capsule per day while rats in group C were fed with normal food. Serum levels of estradiol (E2) and follicular stimulating hormone (FSH) were detected. Expressions of several cytokines, including hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), insulin-like growth factor 1 (IGF-1), and apoptotic factors caspase-3 and p53, were also detected.
Results: Kuntai capsule decoction inhibited apoptosis of in vitro cultured mice ovary cells. Furthermore, the Kuntai capsule promoted the recovery of E2 and FSH to normal levels and regulated the abnormal expression of HGF, VEGF, and IGF-1 and apoptotic factors caspase-3 and p53 in rats with premature ovarian failure after homotopic transplantation of ovarian tissue.
Conclusion: The Kuntai capsule can improve ovarian functions by regulating sexual hormones and cell apoptosis in rats with premature ovarian failure after homotopic transplantation of cryopreserved ovary tissue.
期刊介绍:
Launched in 1995, Alternative Therapies in Health and Medicine has a mission to promote the art and science of integrative medicine and a responsibility to improve public health. We strive to maintain the highest standards of ethical medical journalism independent of special interests that is timely, accurate, and a pleasure to read. We publish original, peer-reviewed scientific articles that provide health care providers with continuing education to promote health, prevent illness, and treat disease. Alternative Therapies in Health and Medicine was the first journal in this field to be indexed in the National Library of Medicine. In 2006, 2007, and 2008, ATHM had the highest impact factor ranking of any independently published peer-reviewed CAM journal in the United States—meaning that its research articles were cited more frequently than any other journal’s in the field.
Alternative Therapies in Health and Medicine does not endorse any particular system or method but promotes the evaluation and appropriate use of all effective therapeutic approaches. Each issue contains a variety of disciplined inquiry methods, from case reports to original scientific research to systematic reviews. The editors encourage the integration of evidence-based emerging therapies with conventional medical practices by licensed health care providers in a way that promotes a comprehensive approach to health care that is focused on wellness, prevention, and healing. Alternative Therapies in Health and Medicine hopes to inform all licensed health care practitioners about developments in fields other than their own and to foster an ongoing debate about the scientific, clinical, historical, legal, political, and cultural issues that affect all of health care.